{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T17:03:43Z","timestamp":1789405423154,"version":"build-2803163510"},"reference-count":52,"publisher":"BMJ","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thorax"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1136\/thoraxjnl-2012-202040","type":"journal-article","created":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T22:12:03Z","timestamp":1354399923000},"page":"867-879","source":"Crossref","is-referenced-by-count":83,"title":["Interventions to improve symptoms and quality of life of patients with fibrotic interstitial lung disease: a systematic review of the literature"],"prefix":"10.1136","volume":"68","author":[{"given":"Sabrina","family":"Bajwah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy R","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet L","family":"Peacock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene J","family":"Higginson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athol U","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit Suresh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Koffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2012,12,1]]},"reference":[{"key":"key-10.1136\/thoraxjnl-2012-202040-1","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1378\/chest.113.2.396","article-title":"Survival in patients with cryptogenic fibrosing alveolitis: a population-based cohort study","volume":"113","author":"Hubbard","year":"1998","journal-title":"Chest"},{"key":"key-10.1136\/thoraxjnl-2012-202040-2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00408-011-9355-7","article-title":"Specialist palliative care is more than drugs: a retrospective study of ILD patients","volume":"190","author":"Bajwah","year":"2012","journal-title":"Lung"},{"key":"key-10.1136\/thoraxjnl-2012-202040-3","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/thx.2004.035220","article-title":"Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review","volume":"60","author":"Swigris","year":"2005","journal-title":"Thorax"},{"key":"key-10.1136\/thoraxjnl-2012-202040-4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"key-10.1136\/thoraxjnl-2012-202040-5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1164\/rccm.201107-1174CI","article-title":"Corticosteroids in respiratory diseases in children","volume":"185","author":"de Benedictis","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.1136\/thoraxjnl-2012-202040-6","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa1002110","article-title":"A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis","volume":"363","author":"Zisman","year":"2010","journal-title":"N Engl J Med"},{"key":"key-10.1136\/thoraxjnl-2012-202040-7","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(11)60405-4","article-title":"Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials","volume":"377","author":"Noble","year":"2011","journal-title":"Lancet"},{"key":"key-10.1136\/thoraxjnl-2012-202040-8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1164\/rccm.200705-732OC","article-title":"BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis","volume":"177","author":"King","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.1136\/thoraxjnl-2012-202040-9","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1183\/09031936.00188108","article-title":"Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1)","volume":"35","author":"Raghu","year":"2010","journal-title":"Eur Respir J"},{"key":"key-10.1136\/thoraxjnl-2012-202040-10","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1440-1843.2007.01205.x","article-title":"Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis","volume":"13","author":"Nishiyama","year":"2008","journal-title":"Respirology"},{"key":"key-10.1136\/thoraxjnl-2012-202040-11","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/thx.2007.088070","article-title":"Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease","volume":"63","author":"Holland","year":"2008","journal-title":"Thorax"},{"key":"key-10.1136\/thoraxjnl-2012-202040-12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/2049-6958-5-1-31","article-title":"Effect of home-based pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis","volume":"5","author":"Ozalevli","year":"2010","journal-title":"Multidisciplinary Respir Med"},{"key":"key-10.1136\/thoraxjnl-2012-202040-13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0761-8425(09)72584-7","article-title":"Home-based pulmonary rehabilitation in idiopathic pulmonary fibrosis","volume":"26","author":"Rammaert","year":"2009","journal-title":"Rev Mal Respir"},{"key":"key-10.1136\/thoraxjnl-2012-202040-14","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000315475","article-title":"Differences in response to pulmonary rehabilitation in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease","volume":"81","author":"Kozu","year":"2011","journal-title":"Respiration"},{"key":"key-10.1136\/thoraxjnl-2012-202040-15","doi-asserted-by":"crossref","first-page":"783","DOI":"10.4187\/respcare.00939","article-title":"Benefits of pulmonary rehabilitation in idiopathic pulmonary fibrosis","volume":"56","author":"Swigris","year":"2011","journal-title":"Respir Care"},{"issue":"(2 Pt 1)","key":"key-10.1136\/thoraxjnl-2012-202040-16","first-page":"646","article-title":"Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)","volume":"161","author":"American Thoracic Society","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.1136\/thoraxjnl-2012-202040-17","first-page":"1345","article-title":"Tratamiento de la fibrosis pulmonar idiop\u00e1tica con colchicina","volume":"126","author":"Undurraga Pereira","year":"1998","journal-title":"Rev m\u00e9d Chile"},{"key":"key-10.1136\/thoraxjnl-2012-202040-18","doi-asserted-by":"crossref","first-page":"633a","DOI":"10.1378\/chest.132.4_MeetingAbstracts.633a","article-title":"A randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of iloprost inhalation in adults with abnormal pulmonary arterial pressure and exercise limitation associated with idiopathic pulmonary fibrosis","volume":"132","author":"Krowka","year":"2007","journal-title":"Chest"},{"key":"key-10.1136\/thoraxjnl-2012-202040-19","first-page":"A45","article-title":"Ambulatory oxygen in idiopathic pulmonary fibrosis: of what benefit?","volume":"62","author":"Hicks","year":"2007","journal-title":"Thorax"},{"key":"key-10.1136\/thoraxjnl-2012-202040-20","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1378\/chest.06-2101","article-title":"Sildenafil improves walk distance in idiopathic pulmonary fibrosis","volume":"131","author":"Collard","year":"2007","journal-title":"Chest"},{"key":"key-10.1136\/thoraxjnl-2012-202040-21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00408-009-9209-8","article-title":"Sildenafil therapy and exercise tolerance in idiopathic pulmonary fibrosis","volume":"188","author":"Jackson","year":"2010","journal-title":"Lung"},{"key":"key-10.1136\/thoraxjnl-2012-202040-22","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1183\/09031936.00190710","article-title":"Ambulatory oxygen in interstitial lung disease","volume":"38","author":"Visca","year":"2011","journal-title":"Eur Respir J"},{"key":"key-10.1136\/thoraxjnl-2012-202040-23","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1183\/09031936.06.00032605","article-title":"Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis","volume":"28","author":"Antoniou","year":"2006","journal-title":"Eur Respir J"},{"key":"key-10.1136\/thoraxjnl-2012-202040-24","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.pupt.2007.02.001","article-title":"A double blind randomised placebo controlled pilot study of oral co-trimoxazole in advanced fibrotic lung disease","volume":"21","author":"Varney","year":"2008","journal-title":"Pulm Pharmacol Ther"},{"key":"key-10.1136\/thoraxjnl-2012-202040-25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1164\/rccm.200312-1670OC","article-title":"Effects of interferon-gamma 1b on biomarker expression in patients with idiopathic pulmonary fibrosis","volume":"170","author":"Strieter","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.1136\/thoraxjnl-2012-202040-26","first-page":"A6838","article-title":"The BUILD-3 trial: a prospective, randomized, double-blind, placebo-controlled study of bosentan in idiopathic pulmonary fibrosis (abstract)","volume":"181","author":"King","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.1136\/thoraxjnl-2012-202040-27","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1191\/0269216305pm998oa","article-title":"Low dose diamorphine reduces breathlessness without causing a fall in oxygen saturation in elderly patients with end-stage idiopathic pulmonary fibrosis","volume":"19","author":"Allen","year":"2005","journal-title":"Palliat Med"},{"key":"key-10.1136\/thoraxjnl-2012-202040-28","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/thx.35.8.593","article-title":"Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival","volume":"35","author":"Turner-Warwick","year":"1980","journal-title":"Thorax"},{"key":"key-10.1136\/thoraxjnl-2012-202040-29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/thx.48.1.68","article-title":"Aerosolised ribavirin in patients with advanced cryptogenic fibrosing alveolitis: a pilot study","volume":"48","author":"Agusti","year":"1993","journal-title":"Thorax"},{"key":"key-10.1136\/thoraxjnl-2012-202040-30","first-page":"105","article-title":"Colchicine, cyclophosphamide and prednisone in the treatment of mild-moderate idiopathic pulmonary fibrosis: comparison of three currently available therapeutic regimens","volume":"12","author":"Fiorucci","year":"2008","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"key-10.1136\/thoraxjnl-2012-202040-31","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1056\/NEJMoa042976","article-title":"High-dose acetylcysteine in idiopathic pulmonary fibrosis","volume":"353","author":"Demedts","year":"2005","journal-title":"N Engl J Med"},{"key":"key-10.1136\/thoraxjnl-2012-202040-32","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0140-6736(09)60551-1","article-title":"Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial","volume":"374","author":"King","year":"2009","journal-title":"The Lancet"},{"key":"key-10.1136\/thoraxjnl-2012-202040-33","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.hrtlng.2009.08.005","article-title":"Impact of a disease-management program on symptom burden and health-related quality of life in patients with idiopathic pulmonary fibrosis and their care partners","volume":"39","author":"Lindell","year":"2010","journal-title":"Heart Lung"},{"key":"key-10.1136\/thoraxjnl-2012-202040-34","first-page":"A589","article-title":"D-penicillamine in the treatment of idiopathic pulmonary fibrosis","volume":"147","author":"Hanania","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"key-10.1136\/thoraxjnl-2012-202040-35","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1164\/rccm.200709-1446OC","article-title":"Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial","volume":"178","author":"Raghu","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.1136\/thoraxjnl-2012-202040-36","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1164\/rccm.200304-597OC","article-title":"A study of the cough reflex in idiopathic pulmonary fibrosis","volume":"168","author":"Hope-Gill","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.1136\/thoraxjnl-2012-202040-37","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/thx.2010.135947","article-title":"Low-dose oral interferon alpha possibly retards the progression of idiopathic pulmonary fibrosis and alleviates associated cough in some patients","volume":"66","author":"Lutherer","year":"2011","journal-title":"Thorax"},{"key":"key-10.1136\/thoraxjnl-2012-202040-38","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/thx.2008.098699","article-title":"Thalidomide inhibits the intractable cough of idiopathic pulmonary fibrosis (letter)","volume":"63","author":"Horton","year":"2008","journal-title":"Thorax"},{"key":"key-10.1136\/thoraxjnl-2012-202040-39","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1440-1843.2005.00725.x","article-title":"A pilot study of aerosolized N-acetylcysteine for idiopathic pulmonary fibrosis","volume":"10","author":"Tomioka","year":"2005","journal-title":"Respirology"},{"key":"key-10.1136\/thoraxjnl-2012-202040-40","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4103\/0970-2113.83972","article-title":"An alternative therapy for idiopathic pulmonary fibrosis by doxycycline through matrix metalloproteinase inhibition","volume":"28","author":"Mishra","year":"2011","journal-title":"Lung India"},{"key":"key-10.1136\/thoraxjnl-2012-202040-41","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2222.1971.tb03020.x","article-title":"Antibodies in some chronic fibrosing lung diseases. II. Immunofluorescent studies","volume":"1","author":"Turner-Warwick","year":"1971","journal-title":"Clin Allergy"},{"key":"key-10.1136\/thoraxjnl-2012-202040-42","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jpainsymman.2011.04.026","article-title":"Dyspnea in idiopathic pulmonary fibrosis: a systematic review","volume":"43","author":"Ryerson","year":"2012","journal-title":"J Pain Symptom Manage"},{"issue":"(4)","key":"key-10.1136\/thoraxjnl-2012-202040-43","first-page":"CD006322","article-title":"Physical training for interstitial lung disease","author":"Holland","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.1136\/thoraxjnl-2012-202040-44","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.rmed.2009.04.024","article-title":"Small changes in six-minute walkdistance are important in diffuse parenchymal lung disease","volume":"103","author":"Holland","year":"2009","journal-title":"Respir Med"},{"key":"key-10.1136\/thoraxjnl-2012-202040-45","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1136\/thx.2009.113498","article-title":"The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference","volume":"65","author":"Swigris","year":"2010","journal-title":"Thorax"},{"key":"key-10.1136\/thoraxjnl-2012-202040-46","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1164\/rccm.201007-1179OC","article-title":"Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference","volume":"183","author":"du Bois","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.1136\/thoraxjnl-2012-202040-47","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/SPC.0b013e3282ff6336","article-title":"Dyspnea in interstitial lung disease","volume":"2","author":"Collard","year":"2008","journal-title":"Curr Opin Support Palliat Care"},{"key":"key-10.1136\/thoraxjnl-2012-202040-48","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1056\/NEJMoa1113354","article-title":"Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis","volume":"366","author":"The Idiopathic Pulmonary Fibrosis Clinical Research Network","year":"2012","journal-title":"N Engl J Med"},{"key":"key-10.1136\/thoraxjnl-2012-202040-49","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/thoraxjnl-2012-201581","article-title":"The development and validation of the King's Brief Interstitial Lung Disease (K-BILD) health status questionnaire","volume":"67","author":"Patel","year":"2012","journal-title":"Thorax"},{"key":"key-10.1136\/thoraxjnl-2012-202040-50","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1136\/thx.2010.139121","article-title":"Development and validity testing of an IPF-specific version of the St George's Respiratory Questionnaire","volume":"65","author":"Yorke","year":"2010","journal-title":"Thorax"},{"key":"key-10.1136\/thoraxjnl-2012-202040-51","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1477-7525-8-77","article-title":"Development of the ATAQ-IPF: a tool to assess quality of life in IPF","volume":"8","author":"Swigris","year":"2010","journal-title":"Health Qual Life Outcomes"},{"key":"key-10.1136\/thoraxjnl-2012-202040-52","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3111\/13696998.2012.680553","article-title":"Burden of illness in idiopathic pulmonary fibrosis","volume":"15","author":"Collard","year":"2012;","journal-title":"J Med Econ"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thoraxjnl-2012-202040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T18:11:54Z","timestamp":1601057514000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thoraxjnl-2012-202040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,1]]},"references-count":52,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2013,8,9]]},"published-print":{"date-parts":[[2013,9]]}},"alternative-id":["10.1136\/thoraxjnl-2012-202040"],"URL":"https:\/\/doi.org\/10.1136\/thoraxjnl-2012-202040","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717969260.793469210","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717969260.793469725","asserted-by":"object"}]},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,1]]}}}